Premature permanent discontinuation of apixaban or warfarin in patients with atrial fibrillation

Posthoc analysis of ARISTOTLE found premature permanent discontinuation of study drug was common, less frequent in patients on apixaban than warfarin and followed by high 30-day rates of death, TED &major bleeding, but no significant difference in clinical outcomes between groups

Source:

Heart